Pembrolizumab for PS2 Patients with Adv. NSCLC: Results of the PePS2 Trial (BMIC-067)

2024/06/2904:08:09 science 180
Pembrolizumab for PS2 Patients with Adv. NSCLC: Results of the PePS2 Trial (BMIC-067) - DayDayNews Pembrolizumab for PS2 Patients with Adv. NSCLC: Results of the PePS2 Trial (BMIC-067) - DayDayNews
4:13
* All content videos are shared, reposted and embedded from YouTube. If there is any violation or error, please contact us to delete it.

Recommended

science Latest News

Site Latest News